Skip to content
BidBenchmark

Contract award

LOVELACE BIOMEDICAL RESEARCH INSTITUTE

RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1
PIID
75A50126F61002
Award key
CONT_AWD_75A50126F61002_7505_75A50122D00021_7505
Recipient UEI
MBT9RXJJ7428
Parent award
CONT_IDV_75A50122D00021_7505
Source as of
Current award value
$3,723,0273
Obligated to date
$3,723,0272
Potential with options
$3,723,0273
Awarding agency
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response
Place of performance
Albuquerque, New Mexico
Set-aside
None
Pricing
Cost Plus Fixed Fee
Competition
Full and Open Competition
Period of performance
Aug 26, 2026Apr 25, 2028Through Apr 25, 2028 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Aug 21, 2026Initial award$3,723,027.43$3,723,027.43

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 24, 2026usaspending_contract_csv@2026.08.2444027ec3cd4
contractor_idUSAspending.govAug 24, 2026usaspending_contract_csv@2026.08.2444027ec3cd4
current_award_valueUSAspending.govAug 24, 2026usaspending_contract_csv@2026.08.2444027ec3cd4
naics_codeUSAspending.govAug 24, 2026usaspending_contract_csv@2026.08.2444027ec3cd4
potential_award_valueUSAspending.govAug 24, 2026usaspending_contract_csv@2026.08.2444027ec3cd4
psc_codeUSAspending.govAug 24, 2026usaspending_contract_csv@2026.08.2444027ec3cd4
total_obligatedUSAspending.govAug 24, 2026usaspending_contract_csv@2026.08.2444027ec3cd4

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 1 transaction records parsed from USAspending.gov, retrieved Aug 24, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
75A50126F61002 — LOVELACE BIOMEDICAL RESEARCH INSTITUTE · BidBenchmark